Analyst Ratings (USA)
The October 12th U.S. analyst updates suggest a selective, cautious outlook, with price-target reductions outnumbering increases roughly two to one. Financials, insurance and real estate received more conservative valuations, although many bullish ratings were retained. Technology sentiment remained divided, combining selected upgrades and higher software targets with cuts across several major growth stocks. Energy showed stronger support through target increases, while healthcare and biotechnology attracted positive coverage alongside substantial differences in valuation.
Updates (477)
10x Genomics (TXG) — Canaccord Genuity maintained its Buy rating and raised its price target to US$100.00 from US$60.00.
10x Genomics (TXG) — Morgan Stanley set a US$70.00 price target.
Aardvark Therapeutics (AARD) — BTIG Research maintained its Neutral rating.
AbCellera Biologics (ABCL) — UBS initiated coverage with a Buy rating and a US$18.00 price target.
Absci (ABSI) — H.C. Wainwright maintained its Buy rating with a US$16.00 price target.
Adaptive Biotechnologies (ADPT) — Morgan Stanley set a US$27.00 price target.
Adobe (ADBE) — Wells Fargo downgraded its rating to Underweight from Overweight and lowered its price target to US$225.00 from US$270.00.
AerCap (AER) — TD Cowen maintained its Buy rating and raised its price target to US$185.00 from US$180.00.
AEVEX (AVEX) — RBC Capital Markets maintained its Outperform rating and lowered its price target to US$26.00 from US$31.00.
Affiliated Managers Group (AMG) — TD Cowen maintained its Buy rating and raised its price target to US$523.00 from US$512.00.
Aflac (AFL) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$116.00 from US$122.00.
Agilysys (AGYS) — Oppenheimer maintained its Outperform rating.
Airbnb (ABNB) — Bernstein maintained its Outperform rating.
Alexander’s (ALX) — Piper Sandler maintained its Underweight rating and lowered its price target to US$192.00 from US$212.00.
Alexandria Real Estate Equities (ARE) — BMO Capital Markets downgraded its rating to Underperform from Market Perform with a US$41.00 price target.
Alexandria Real Estate Equities (ARE) — Raymond James set a US$41.00 price target.
Alexandria Real Estate Equities (ARE) — RBC Capital Markets set a US$41.00 price target.
Alibaba Group (BABA) — JPMorgan maintained its Overweight rating and lowered its price target to US$200.00 from US$210.00.
Alignment Healthcare (ALHC) — Raymond James maintained its Outperform rating.
Alignment Healthcare (ALHC) — TD Cowen maintained its Buy rating and lowered its price target to US$12.00 from US$21.00.
Alignment Healthcare (ALHC) — UBS maintained its Neutral rating with a US$9.00 price target.
AllianceBernstein (AB) — TD Cowen maintained its Hold rating and lowered its price target to US$36.00 from US$38.00.
Alliant Energy (LNT) — Jefferies maintained its Buy rating with a US$75.00 price target.
Allison Transmission (ALSN) — Citigroup upgraded its rating to Buy from Neutral with a US$135.00 price target.
Allstate (ALL) — BofA Securities maintained its Buy rating and raised its price target to US$340.00 from US$336.00.
Allstate (ALL) — Keefe, Bruyette & Woods maintained its Underperform rating and lowered its price target to US$232.00 from US$250.00.
Allstate (ALL) — Wells Fargo upgraded its rating to Equal Weight from Underweight and lowered its price target to US$236.00 from US$250.00.
Ally Financial (ALLY) — JPMorgan maintained its Overweight rating and lowered its price target to US$43.00 from US$48.00.
Ally Financial (ALLY) — Morgan Stanley downgraded its rating to Equal Weight from Overweight and lowered its price target to US$43.00 from US$55.00.
Alphabet (GOOGL) — Cantor Fitzgerald maintained its Overweight rating with a US$420.00 price target.
Amazon.com (AMZN) — Cantor Fitzgerald maintained its Overweight rating and lowered its price target to US$310.00 from US$320.00.
Amazon.com (AMZN) — Wells Fargo maintained its Overweight rating and lowered its price target to US$329.00 from US$338.00.
American Bitcoin (ABTC) — H.C. Wainwright resumed coverage with a Buy rating and a US$22.00 price target.
American Bitcoin (ABTC) — Maxim Group set a US$16.00 price target.
American Express (AXP) — JPMorgan maintained its Overweight rating and lowered its price target to US$360.00 from US$400.00.
American Express (AXP) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$380.00 from US$382.00.
American Financial Group (AFG) — Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to US$147.00 from US$153.00.
American Financial Group (AFG) — Wells Fargo maintained its Overweight rating and lowered its price target to US$166.00 from US$175.00.
American Integrity Insurance Group (AII) — Citigroup maintained its Outperform rating.
American Integrity Insurance Group (AII) — Citizens JMP maintained its Market Outperform rating and raised its price target to US$29.00 from US$26.00.
American Integrity Insurance Group (AII) — Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to US$31.00 from US$29.00.
American International Group (AIG) — Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$90.00 from US$96.00.
American International Group (AIG) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$83.00 from US$85.00.
American Savings Bank, N.A. (ASBH) — DA Davidson initiated coverage with a Buy rating and a US$20.00 price target.
American Savings Bank, N.A. (ASBH) — Keefe, Bruyette & Woods initiated coverage with a Market Perform rating and a US$19.00 price target.
American Savings Bank, N.A. (ASBH) — Piper Sandler initiated coverage with an Overweight rating and a US$20.00 price target.
American Savings Bank, N.A. (ASBH) — Stephens initiated coverage with an Overweight rating and a US$21.00 price target.
Americold Realty Trust (COLD) — Piper Sandler maintained its Neutral rating and lowered its price target to US$15.00 from US$17.00.
AMERISAFE (AMSF) — Citigroup maintained its Market Outperform rating.
AMERISAFE (AMSF) — Citizens JMP maintained its Market Outperform rating and lowered its price target to US$40.00 from US$42.00.
AMERISAFE (AMSF) — Morgan Stanley set a US$40.00 price target.
AMETEK (AME) — Citigroup maintained its Neutral rating.
Amgen (AMGN) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$415.00 from US$450.00.
Amgen (AMGN) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$430.00 from US$435.00.
Amrize (AMRZ) — Longbow Research initiated coverage with a Buy rating.
AON (AON) — Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$342.00 from US$417.00.
AON (AON) — Wells Fargo maintained its Overweight rating and lowered its price target to US$323.00 from US$383.00.
APA (APA) — Truist Securities maintained its Hold rating and raised its price target to US$45.00 from US$44.00.
APA (APA) — UBS maintained its Neutral rating with a US$52.00 price target.
APi Group (APG) — Citigroup maintained its Buy rating.
Apollo Global Management (APO) — TD Cowen maintained its Buy rating and lowered its price target to US$154.00 from US$159.00.
AppLovin (APP) — Oppenheimer maintained its Outperform rating and lowered its price target to US$490.00 from US$560.00.
Aptiv (APTV) — RBC Capital Markets maintained its Outperform rating and lowered its price target to US$77.00 from US$78.00.
Aramark (ARMK) — Citigroup maintained its Buy rating.
Arch Capital Group (ACGL) — Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to US$95.00 from US$99.00.
Arch Capital Group (ACGL) — Wells Fargo maintained its Overweight rating and lowered its price target to US$107.00 from US$117.00.
Archer Daniels Midland (ADM) — JPMorgan maintained its Underweight rating and lowered its price target to US$75.00 from US$77.00.
Ares Management (ARES) — TD Cowen maintained its Buy rating and lowered its price target to US$159.00 from US$163.00.
argenx (ARGX) — Oppenheimer maintained its Outperform rating and lowered its price target to US$1,038.00 from US$1,100.00.
Arthur J. Gallagher & Co. (AJG) — Wells Fargo maintained its Overweight rating and lowered its price target to US$284.00 from US$291.00.
Artisan Partners Asset Management (APAM) — TD Cowen maintained its Hold rating and lowered its price target to US$33.00 from US$37.00.
AST SpaceMobile (ASTS) — Deutsche Bank upgraded its rating to Buy from Hold with a US$93.00 price target.
Ategrity Specialty (ASIC) — Wells Fargo maintained its Overweight rating and raised its price target to US$31.00 from US$30.00.
Atlassian (TEAM) — RBC Capital Markets maintained its Outperform rating and raised its price target to US$235.00 from US$215.00.
AtriCure (ATRC) — BTIG Research maintained its Buy rating and raised its price target to US$63.00 from US$55.00.
Autoliv (ALV) — RBC Capital Markets maintained its Outperform rating and lowered its price target to US$146.00 from US$147.00.
Avery Dennison (AVY) — Truist Securities maintained its Buy rating and lowered its price target to US$208.00 from US$209.00.
Avita Medical (RCEL) — BTIG Research maintained its Buy rating and raised its price target to US$15.00 from US$11.00.
Axis Capital (AXS) — Wells Fargo maintained its Overweight rating and lowered its price target to US$112.00 from US$126.00.
AxoGen (AXGN) — BofA Securities initiated coverage with a Buy rating and a US$52.00 price target.
Baldwin Insurance Group (BWIN) — Keefe, Bruyette & Woods downgraded its rating to Market Perform from Outperform with a US$32.50 price target.
Baldwin Insurance Group (BWIN) — TD Cowen downgraded its rating to Hold from Buy and lowered its price target to US$32.50 from US$37.00.
Beta Bionics (BBNX) — Jefferies initiated coverage with a Buy rating and a US$30.00 price target.
Better Home & Finance (BETR) — BTIG Research maintained its Buy rating and lowered its price target to US$20.00 from US$23.00.
BioAge Labs (BIOA) — UBS initiated coverage with a Neutral rating and a US$8.00 price target.
Biogen (BIIB) — BMO Capital Markets maintained its Market Perform rating with a US$220.00 price target.
Biogen (BIIB) — JPMorgan upgraded its rating to Overweight from Neutral and raised its price target to US$300.00 from US$210.00.
BioMarin Pharmaceutical (BMRN) — Raymond James upgraded its rating to Strong Buy from Outperform with a US$109.00 price target.
BlackRock (BLK) — TD Cowen maintained its Hold rating and raised its price target to US$1,212.00 from US$1,190.00.
Blackstone (BX) — Citigroup upgraded its rating to Buy from Market Outperform.
Blackstone (BX) — TD Cowen maintained its Buy rating and lowered its price target to US$144.00 from US$154.00.
Blackstone Digital Infrastructure Trust (BXDC) — Citigroup upgraded its rating to Buy from Neutral and lowered its price target to US$20.00 from US$23.00.
Blue Owl Capital (OWL) — TD Cowen maintained its Buy rating and raised its price target to US$16.00 from US$15.00.
Boeing (BA) — Bernstein maintained its Outperform rating and lowered its price target to US$278.00 from US$298.00.
Booking (BKNG) — Cantor Fitzgerald maintained its Neutral rating and lowered its price target to US$170.00 from US$220.00.
Boyd Gaming (BYD) — Citigroup maintained its Neutral rating.
BRAEMAR HOTELS & RESORTS (BHR) — Robert W. Baird maintained its Neutral rating and lowered its price target to US$2.00 from US$2.50.
Brixmor Property Group (BRX) — Piper Sandler maintained its Overweight rating and lowered its price target to US$36.00 from US$40.00.
Brookfield Business (BBUC) — TD Cowen maintained its Hold rating and lowered its price target to US$29.00 from US$32.00.
Brown & Brown (BRO) — Citigroup maintained its Market Outperform rating.
Brown & Brown (BRO) — Citizens JMP maintained its Market Outperform rating and lowered its price target to US$75.00 from US$78.00.
Brown & Brown (BRO) — Keefe, Bruyette & Woods upgraded its rating to Outperform from Market Perform with a US$77.00 price target.
Brown & Brown (BRO) — TD Cowen initiated coverage with a Buy rating and a US$82.00 price target.
Brown & Brown (BRO) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$68.00 from US$69.00.
Bunge Global (BG) — JPMorgan maintained its Overweight rating and lowered its price target to US$139.00 from US$140.00.
Butterfly Network (BFLY) — Canaccord Genuity initiated coverage with a Buy rating and a US$10.00 price target.
BXP (BXP) — Piper Sandler maintained its Overweight rating and lowered its price target to US$72.00 from US$88.00.
Byrna Technologies (BYRN) — B. Riley Financial maintained its Buy rating and lowered its price target to US$11.00 from US$12.00.
C.H. Robinson Worldwide (CHRW) — Deutsche Bank downgraded its rating to Hold from Buy with a US$153.00 price target.
C3.ai (AI) — Northland Securities upgraded its rating to Outperform from Market Perform and raised its price target to US$16.00 from US$10.00.
California Resources (CRC) — UBS maintained its Buy rating.
Camden Property Trust (CPT) — Piper Sandler maintained its Neutral rating and lowered its price target to US$102.00 from US$119.00.
Capital One Financial (COF) — JPMorgan maintained its Overweight rating and lowered its price target to US$227.00 from US$246.00.
Capital One Financial (COF) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$267.00 from US$273.00.
Carlsmed (CARL) — BTIG Research maintained its Buy rating and raised its price target to US$24.00 from US$23.00.
Carlyle Group (CG) — TD Cowen maintained its Hold rating and lowered its price target to US$42.00 from US$54.00.
Carter’s (CRI) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$30.00 from US$42.00.
Caterpillar (CAT) — Citigroup maintained its Buy rating.
Cencora (COR) — Robert W. Baird maintained its Outperform rating and raised its price target to US$373.00 from US$370.00.
CenterPoint Energy (CNP) — Truist Securities maintained its Buy rating and lowered its price target to US$44.00 from US$46.00.
Centerspace (CSR) — Piper Sandler maintained its Neutral rating and lowered its price target to US$56.00 from US$58.00.
Charles River Laboratories International (CRL) — Morgan Stanley maintained its Overweight rating with a US$340.00 price target.
Charles Schwab (SCHW) — Evercore ISI initiated coverage with a In-Line rating and a US$107.00 price target.
Charles Schwab (SCHW) — TD Cowen maintained its Buy rating and raised its price target to US$129.00 from US$128.00.
Chemung Financial (CHMG) — Hovde Group initiated coverage with a Market Perform rating and a US$88.00 price target.
Chevron (CVX) — Mizuho set a US$234.00 price target.
Chevron (CVX) — TD Cowen maintained its Hold rating and raised its price target to US$225.00 from US$215.00.
Choice Hotels International (CHH) — Morgan Stanley maintained its Underweight rating and raised its price target to US$92.00 from US$91.00.
Chord Energy (CHRD) — Truist Securities maintained its Buy rating and raised its price target to US$195.00 from US$180.00.
Chubb (CB) — Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$387.00 from US$389.00.
Chubb (CB) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$343.00 from US$356.00.
Cincinnati Financial (CINF) — Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to US$171.00 from US$190.00.
Cipher Mining (CIFR) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$51.50 from US$54.00.
Citizens (CIZN) — Morgan Stanley set a US$29.00 price target.
Climb Bio (CLYM) — H.C. Wainwright maintained its Buy rating.
Cloudflare (NET) — Barclays maintained its Overweight rating with a US$400.00 price target.
Community Financial System (CBU) — DA Davidson maintained its Neutral rating and lowered its price target to US$69.00 from US$70.00.
Community Healthcare Trust (CHCT) — Piper Sandler maintained its Neutral rating and lowered its price target to US$14.00 from US$17.00.
CommVault Systems (CVLT) — RBC Capital Markets maintained its Sector Perform rating and raised its price target to US$160.00 from US$150.00.
Compass (COMP) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$10.00 from US$13.00.
Compugen (CGEN) — H.C. Wainwright maintained its Buy rating with a US$4.00 price target.
Connect Biopharma (CNTB) — Leerink Partners resumed coverage with an Outperform rating and a US$4.00 price target.
Corebridge Financial (CRBG) — Piper Sandler maintained its Overweight rating and raised its price target to US$40.00 from US$38.00.
Corebridge Financial (CRBG) — Wells Fargo maintained its Overweight rating and raised its price target to US$40.00 from US$39.00.
Corteva (CTVA) — UBS set a US$15.00 price target.
Crescent Energy (CRGY) — UBS maintained its Buy rating with a US$18.00 price target.
Curbline Properties (CURB) — Piper Sandler maintained its Overweight rating and lowered its price target to US$38.00 from US$39.00.
CVS Health (CVS) — Leerink Partners maintained its Outperform rating and lowered its price target to US$112.00 from US$119.00.
D.R. Horton (DHI) — Goldman Sachs maintained its Buy rating with a US$182.00 price target.
Danaher (DHR) — Morgan Stanley maintained its Overweight rating with a US$240.00 price target.
Darling Ingredients (DAR) — JPMorgan maintained its Overweight rating and raised its price target to US$83.00 from US$82.00.
Datadog (DDOG) — RBC Capital Markets maintained its Outperform rating and raised its price target to US$320.00 from US$280.00.
Delta Air Lines (DAL) — Argus set a US$95.00 price target.
Delta Air Lines (DAL) — BMO Capital Markets maintained its Outperform rating and raised its price target to US$105.00 from US$100.00.
Delta Air Lines (DAL) — Susquehanna set a US$95.00 price target.
Delta Air Lines (DAL) — UBS set a US$102.00 price target.
DexCom (DXCM) — BTIG Research maintained its Buy rating and raised its price target to US$96.00 from US$90.00.
DiamondRock Hospitality (DRH) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$12.00 from US$11.00.
Dominion Energy (D) — Truist Securities maintained its Hold rating and lowered its price target to US$62.00 from US$66.00.
DoorDash (DASH) — Cantor Fitzgerald maintained its Overweight rating and lowered its price target to US$240.00 from US$260.00.
Douglas Emmett (DEI) — Piper Sandler maintained its Neutral rating and lowered its price target to US$11.00 from US$14.00.
Dr. Reddy’s Laboratories (RDY) — BNP Paribas Exane upgraded its rating to Outperform with a US$14.80 price target.
Duke Energy (DUK) — Jefferies maintained its Hold rating with a US$121.00 price target.
Duke Energy (DUK) — Truist Securities maintained its Buy rating and lowered its price target to US$130.00 from US$135.00.
Dynatrace (DT) — RBC Capital Markets maintained its Outperform rating and raised its price target to US$73.00 from US$59.00.
EastGroup Properties (EGP) — Piper Sandler maintained its Overweight rating and lowered its price target to US$246.00 from US$268.00.
Eaton (ETN) — Citigroup maintained its Buy rating.
eBay (EBAY) — Morgan Stanley maintained its Overweight rating and raised its price target to US$132.00 from US$127.00.
eBay (EBAY) — Wells Fargo maintained its Underweight rating and lowered its price target to US$91.00 from US$92.00.
Edison International (EIX) — JPMorgan maintained its Neutral rating and lowered its price target to US$59.00 from US$61.00.
Edison International (EIX) — Truist Securities maintained its Hold rating and lowered its price target to US$62.00 from US$63.00.
Elevance Health (ELV) — Guggenheim maintained its Buy rating and raised its price target to US$460.00 from US$455.00.
Eli Lilly and Company (LLY) — RBC Capital Markets maintained its Outperform rating with a US$1,500.00 price target.
Enact Holdings (ACT) — JPMorgan downgraded its rating to Underweight from Neutral with a US$44.00 price target.
Endava (DAVA) — Needham & Company maintained its Buy rating with a US$5.00 price target.
Enovis (ENOV) — Needham & Company maintained its Buy rating and lowered its price target to US$34.00 from US$52.00.
Entergy (ETR) — Truist Securities maintained its Buy rating and lowered its price target to US$119.00 from US$122.00.
Equillium (EQ) — Leerink Partners resumed coverage with an Outperform rating and a US$6.00 price target.
Equitable (EQH) — Wells Fargo maintained its Overweight rating and raised its price target to US$65.00 from US$64.00.
Essent Group (ESNT) — JPMorgan maintained its Neutral rating and lowered its price target to US$66.00 from US$72.00.
Essex Property Trust (ESS) — Piper Sandler maintained its Overweight rating and lowered its price target to US$326.00 from US$352.00.
Ethos Technologies Inc. Class A Common Stock (LIFE) — Citigroup maintained its Market Outperform rating.
Ethos Technologies Inc. Class A Common Stock (LIFE) — Citizens JMP maintained its Market Outperform rating and raised its price target to US$40.00 from US$33.00.
eToro Group (ETOR) — TD Cowen maintained its Buy rating and lowered its price target to US$33.00 from US$35.00.
EVA Live (GOAI) — Maxim Group initiated coverage with a Buy rating and a US$7.00 price target.
Everest Group (EG) — Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$407.00 from US$414.00.
Everpure (P) — Cantor Fitzgerald maintained its Neutral rating.
Everpure (P) — Guggenheim maintained its Buy rating and raised its price target to US$215.00 from US$150.00.
Everspin Tech (MRAM) — Maxim Group initiated coverage with a Buy rating and a US$25.00 price target.
Evommune (EVMN) — UBS initiated coverage with a Neutral rating and a US$8.00 price target.
F5 (FFIV) — RBC Capital Markets maintained its Outperform rating and raised its price target to US$525.00 from US$508.00.
Fannie Mae (FNMA) — Mizuho downgraded its rating to Neutral from Outperform with a US$5.00 price target.
Federal Realty Investment Trust (FRT) — Piper Sandler set a US$131.00 price target.
Federated Hermes (FHI) — TD Cowen maintained its Hold rating and lowered its price target to US$56.00 from US$60.00.
Figma (FIG) — Wells Fargo set a US$30.00 price target.
First Financial Corporation (THFF) — Hovde Group initiated coverage with an Outperform rating and a US$85.00 price target.
First Solar (FSLR) — Truist Securities upgraded its rating to Buy from Hold and raised its price target to US$270.00 from US$229.00.
FirstEnergy (FE) — Mizuho set a US$47.00 price target.
Ford Motor (F) — JPMorgan maintained its Overweight rating and lowered its price target to US$16.00 from US$17.00.
Fortinet (FTNT) — Barclays set a US$210.00 price target.
Fortinet (FTNT) — RBC Capital Markets maintained its Sector Perform rating and raised its price target to US$205.00 from US$185.00.
Franklin Resources (BEN) — JPMorgan maintained its Neutral rating and raised its price target to US$35.00 from US$34.00.
Franklin Resources (BEN) — TD Cowen maintained its Buy rating and lowered its price target to US$38.00 from US$40.00.
Freddie Mac (FMCC) — Mizuho downgraded its rating to Neutral from Outperform with a US$4.00 price target.
Fresenius Medical Care AG & Co. KGaA (FMS) — Truist Securities maintained its Hold rating and lowered its price target to US$24.00 from US$25.00.
Frontdoor (FTDR) — Goldman Sachs maintained its Neutral rating and lowered its price target to US$81.00 from US$91.00.
GE HealthCare Technologies (GEHC) — BTIG Research maintained its Buy rating and lowered its price target to US$75.00 from US$79.00.
Gen Digital (GEN) — RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$24.00 from US$26.00.
General Motors (GM) — JPMorgan maintained its Overweight rating and lowered its price target to US$110.00 from US$120.00.
General Motors (GM) — RBC Capital Markets maintained its Outperform rating and raised its price target to US$102.00 from US$100.00.
Genuine Parts (GPC) — JPMorgan maintained its Overweight rating and raised its price target to US$137.00 from US$125.00.
Gilead Sciences (GILD) — BofA Securities maintained its Buy rating with a US$164.00 price target.
Glaukos (GKOS) — BTIG Research maintained its Buy rating and raised its price target to US$205.00 from US$202.00.
Globe Life (GL) — Wells Fargo maintained its Overweight rating and raised its price target to US$191.00 from US$190.00.
GoDaddy (GDDY) — RBC Capital Markets downgraded its rating to Sector Perform from Outperform with a US$95.00 price target.
Goosehead Insurance (GSHD) — Citigroup maintained its Market Outperform rating.
Goosehead Insurance (GSHD) — Citizens JMP maintained its Market Outperform rating and lowered its price target to US$80.00 from US$100.00.
Goosehead Insurance (GSHD) — Deutsche Bank set a US$80.00 price target.
Goosehead Insurance (GSHD) — Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$66.00 from US$72.00.
GRAIL (GRAL) — Morgan Stanley set a US$120.00 price target.
Graphic Packaging (GPK) — Truist Securities maintained its Hold rating and lowered its price target to US$9.00 from US$11.00.
Greif (GEF) — Truist Securities maintained its Hold rating and lowered its price target to US$94.00 from US$97.00.
Guardant Health (GH) — Morgan Stanley maintained its Overweight rating with a US$200.00 price target.
Hamilton Insurance Group (HG) — Wells Fargo maintained its Overweight rating and lowered its price target to US$40.00 from US$41.00.
Harmony Biosciences (HRMY) — Needham & Company maintained its Buy rating with a US$50.00 price target.
HCA Healthcare (HCA) — TD Cowen maintained its Buy rating and raised its price target to US$460.00 from US$431.00.
Helmerich & Payne (HP) — BofA Securities maintained its Buy rating.
Helmerich & Payne (HP) — UBS maintained its Buy rating with a US$50.00 price target.
Hemab Therapeutics (COAG) — Rodman & Renshaw initiated coverage with a Buy rating and a US$56.00 price target.
Herc (HRI) — Citigroup maintained its Buy rating.
Hexcel (HXL) — Seaport Research Partners upgraded its rating to Buy from Neutral with a US$104.00 price target.
Hilton Worldwide (HLT) — Morgan Stanley maintained its Overweight rating and raised its price target to US$336.00 from US$332.00.
Hinge Health (HNGE) — Barclays maintained its Overweight rating with a US$110.00 price target.
Host Hotels & Resorts (HST) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$24.00 from US$22.00.
Howard Hughes (HHH) — Piper Sandler maintained its Overweight rating and lowered its price target to US$83.00 from US$100.00.
Hub Group (HUBG) — Robert W. Baird upgraded its rating to Outperform from Neutral with a US$29.00 price target.
HubSpot (HUBS) — Barclays downgraded its rating to Equal Weight from Overweight with a US$240.00 price target.
HubSpot (HUBS) — UBS downgraded its rating to Cautious from Positive with a US$240.00 price target.
Hudson Pacific Properties (HPP) — Piper Sandler maintained its Overweight rating and lowered its price target to US$15.00 from US$18.00.
Humana (HUM) — Oppenheimer set a US$525.00 price target.
Humana (HUM) — Raymond James upgraded its rating to Outperform from Market Perform with a US$520.00 price target.
Humana (HUM) — Truist Securities maintained its Hold rating and raised its price target to US$475.00 from US$415.00.
Humana (HUM) — UBS maintained its Neutral rating.
Hyatt Hotels (H) — Morgan Stanley maintained its Overweight rating and raised its price target to US$211.00 from US$209.00.
IDEXX Laboratories (IDXX) — KeyBanc Capital Markets initiated coverage with a Sector Weight rating.
IDEXX Laboratories (IDXX) — KeyCorp initiated coverage with a Sector Weight rating.
Ingersoll Rand (IR) — Citigroup maintained its Buy rating.
Innovative Industrial Properties (IIPR) — Piper Sandler maintained its Underweight rating and lowered its price target to US$44.00 from US$51.00.
Insmed (INSM) — BofA Securities maintained its Buy rating with a US$207.00 price target.
Insmed (INSM) — H.C. Wainwright maintained its Buy rating with a US$220.00 price target.
Insmed (INSM) — Wolfe Research downgraded its rating to Peer Perform from Outperform.
Installed Building Products (IBP) — Goldman Sachs maintained its Buy rating and lowered its price target to US$257.00 from US$297.00.
Insulet (PODD) — Jefferies maintained its Buy rating and lowered its price target to US$190.00 from US$275.00.
Intapp (INTA) — Barclays maintained its Underweight rating with a US$38.00 price target.
Interactive Brokers Group (IBKR) — Deutsche Bank initiated coverage with a Buy rating and a US$102.00 price target.
Interactive Brokers Group (IBKR) — Evercore ISI initiated coverage with an Outperform rating and a US$100.00 price target.
Intercontinental Exchange (ICE) — TD Cowen maintained its Hold rating and raised its price target to US$167.00 from US$166.00.
International Paper (IP) — Truist Securities maintained its Buy rating and lowered its price target to US$41.00 from US$49.00.
Intuitive Surgical (ISRG) — BTIG Research maintained its Buy rating and lowered its price target to US$454.00 from US$469.00.
Invesco (IVZ) — TD Cowen maintained its Buy rating and lowered its price target to US$38.00 from US$39.00.
Invitation Home (INVH) — UBS maintained its Buy rating with a US$31.00 price target.
Kardigan (KARD) — UBS initiated coverage with a Buy rating and a US$25.00 price target.
KB Home (KBH) — Goldman Sachs set a US$56.00 price target.
Kimball Electronics (KE) — Cantor Fitzgerald maintained its Overweight rating.
Kimco Realty (KIM) — Piper Sandler maintained its Overweight rating and lowered its price target to US$27.00 from US$31.00.
Kinsale Capital Group (KNSL) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$348.00 from US$377.00.
Kite Realty Group Trust (KRG) — Piper Sandler maintained its Neutral rating and lowered its price target to US$27.00 from US$33.00.
KKR & Co. Inc. (KKR) — TD Cowen maintained its Hold rating and lowered its price target to US$103.00 from US$118.00.
Kodiak Gas Services (KGS) — Mizuho set a US$72.00 price target.
Kodiak Sciences (KOD) — H.C. Wainwright maintained its Buy rating and raised its price target to US$126.00 from US$96.00.
Kratos Defense & Security Solutions (KTOS) — Goldman Sachs maintained its Buy rating and lowered its price target to US$77.00 from US$88.00.
L3Harris Technologies (LHX) — Goldman Sachs maintained its Buy rating and lowered its price target to US$361.00 from US$405.00.
Las Vegas Sands (LVS) — Citigroup initiated coverage with a Buy rating and a US$71.50 price target.
Latham Group (SWIM) — Goldman Sachs maintained its Sell rating.
LB Pharmaceuticals (LBRX) — Guggenheim maintained its Buy rating.
LB Pharmaceuticals (LBRX) — H.C. Wainwright maintained its Buy rating.
LB Pharmaceuticals (LBRX) — Raymond James upgraded its rating to Buy.
Lear (LEA) — RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$139.00 from US$143.00.
Lincoln National (LNC) — Wells Fargo maintained its Overweight rating and raised its price target to US$54.00 from US$52.00.
Lineage (LINE) — Piper Sandler maintained its Neutral rating and lowered its price target to US$36.00 from US$44.00.
Louisiana-Pacific (LPX) — Goldman Sachs maintained its Sell rating and lowered its price target to US$64.00 from US$74.00.
LPL Financial (LPLA) — TD Cowen maintained its Hold rating and raised its price target to US$380.00 from US$377.00.
Lucid Group (LCID) — Cantor Fitzgerald maintained its Neutral rating.
Lucid Group (LCID) — RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$4.00 from US$7.00.
Macerich (MAC) — Piper Sandler maintained its Overweight rating and lowered its price target to US$26.00 from US$30.00.
Madison Air Solutions (MAIR) — Citigroup maintained its Buy rating.
Magna International (MGA) — RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$68.00 from US$69.00.
Manhattan Associates (MANH) — Morgan Stanley upgraded its rating to Overweight from Equal Weight and raised its price target to US$250.00 from US$180.00.
Marriott International (MAR) — Morgan Stanley maintained its Overweight rating and raised its price target to US$384.00 from US$380.00.
Marsh & McLennan Companies (MRSH) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$183.00 from US$188.00.
MasTec (MTZ) — Cantor Fitzgerald maintained its Overweight rating with a US$348.00 price target.
Mattel (MAT) — Seaport Research Partners upgraded its rating to Buy from Neutral with a US$20.00 price target.
MBX Biosciences (MBX) — Stifel Nicolaus maintained its Buy rating and raised its price target to US$84.00 from US$70.00.
Medtronic (MDT) — BTIG Research maintained its Buy rating and lowered its price target to US$99.00 from US$100.00.
Melco Resorts & Entertainment (MLCO) — Citigroup initiated coverage with a Buy rating and a US$9.40 price target.
MercadoLibre (MELI) — Cantor Fitzgerald maintained its Overweight rating and lowered its price target to US$2,200.00 from US$2,300.00.
Merck & Co., Inc. (MRK) — RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$145.00 from US$150.00.
Meritage Homes (MTH) — Goldman Sachs maintained its Buy rating and lowered its price target to US$82.00 from US$93.00.
Meta Platforms (META) — Cantor Fitzgerald maintained its Overweight rating and lowered its price target to US$840.00 from US$860.00.
MetLife (MET) — Wells Fargo maintained its Overweight rating and raised its price target to US$110.00 from US$109.00.
MGM Resorts International (MGM) — Citigroup maintained its Neutral rating.
Microsoft (MSFT) — Deutsche Bank maintained its Buy rating with a US$600.00 price target.
Mid-America Apartment Communities (MAA) — Piper Sandler maintained its Neutral rating and lowered its price target to US$121.00 from US$140.00.
Mineralys Therapeutics (MLYS) — H.C. Wainwright maintained its Buy rating with a US$56.00 price target.
Mineralys Therapeutics (MLYS) — UBS initiated coverage with a Neutral rating and a US$29.00 price target.
MiniMed Group (MMED) — Jefferies initiated coverage with a Hold rating and a US$22.00 price target.
Mirum Pharmaceuticals (MIRM) — H.C. Wainwright maintained its Buy rating and raised its price target to US$200.00 from US$195.00.
Mirum Pharmaceuticals (MIRM) — TD Cowen maintained its Buy rating.
monday.com (MNDY) — Barclays downgraded its rating to Equal Weight from Overweight with a US$100.00 price target.
Nasdaq (NDAQ) — TD Cowen maintained its Buy rating and lowered its price target to US$107.00 from US$108.00.
Natera (NTRA) — Morgan Stanley maintained its Overweight rating with a US$435.00 price target.
Navient (NAVI) — JPMorgan maintained its Neutral rating and raised its price target to US$8.50 from US$8.00.
nCino (NCNO) — KeyCorp maintained its Sector Weight rating.
Nektar Therapeutics (NKTR) — Leerink Partners initiated coverage with an Outperform rating and a US$130.00 price target.
Nektar Therapeutics (NKTR) — UBS initiated coverage with a Neutral rating and a US$53.00 price target.
Neptune Insurance (NP) — Wells Fargo maintained its Overweight rating and lowered its price target to US$34.00 from US$37.00.
Neurocrine Biosciences (NBIX) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$150.00 from US$164.00.
Newmark Group (NMRK) — Piper Sandler maintained its Overweight rating and lowered its price target to US$14.00 from US$19.00.
NMI (NMIH) — JPMorgan maintained its Overweight rating and lowered its price target to US$45.00 from US$50.00.
Norwegian Cruise Line (NCLH) — Wells Fargo maintained its Overweight rating and lowered its price target to US$18.00 from US$20.00.
Novo Nordisk A/S (NVO) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$40.00 from US$47.00.
Nutrien (NTR) — Jefferies maintained its Hold rating with a US$71.00 price target.
nVent Electric (NVT) — Citigroup maintained its Buy rating.
O-I Glass (OI) — Truist Securities maintained its Buy rating and lowered its price target to US$8.00 from US$10.00.
Ocular Therapeutix (OCUL) — UBS initiated coverage with a Buy rating and a US$14.00 price target.
Odyssey Therapeutics (ODTX) — UBS initiated coverage with a Buy rating and a US$27.00 price target.
Ollie’s Bargain Outlet (OLLI) — Piper Sandler maintained its Overweight rating.
OneMain (OMF) — JPMorgan maintained its Underweight rating and lowered its price target to US$52.00 from US$60.00.
Onity Group (ONIT) — BTIG Research maintained its Buy rating and lowered its price target to US$45.00 from US$50.00.
Option Care Health (OPCH) — Morgan Stanley set a US$32.05 price target.
Oscar Health (OSCR) — UBS maintained its Neutral rating with a US$36.00 price target.
Ovintiv (OVV) — Truist Securities maintained its Buy rating and raised its price target to US$77.00 from US$73.00.
Owens Corning (OC) — Goldman Sachs maintained its Neutral rating and lowered its price target to US$128.00 from US$169.00.
Pacific Gas & Electric (PCG) — Barclays set a US$17.00 price target.
Pacific Gas & Electric (PCG) — JPMorgan maintained its Overweight rating and lowered its price target to US$17.00 from US$18.00.
Packaging Corporation of America (PKG) — Truist Securities maintained its Buy rating and raised its price target to US$280.00 from US$270.00.
Palantir Technologies (PLTR) — Robert W. Baird set a US$250.00 price target.
Palo Alto Networks (PANW) — Wells Fargo maintained its Overweight rating with a US$525.00 price target.
Palvella Therapeutics (PVLA) — H.C. Wainwright maintained its Buy rating and lowered its price target to US$246.00 from US$270.00.
Park Hotels & Resorts (PK) — Morgan Stanley maintained its Equal Weight rating and raised its price target to US$13.00 from US$11.00.
Parker-Hannifin (PH) — Citigroup maintained its Buy rating.
Pebblebrook Hotel Trust (PEB) — Morgan Stanley maintained its Underweight rating and raised its price target to US$14.00 from US$13.00.
PennyMac Financial Services (PFSI) — BTIG Research maintained its Buy rating and lowered its price target to US$80.00 from US$90.00.
Permian Resources (PR) — Citigroup maintained its Buy rating.
Permian Resources (PR) — Truist Securities maintained its Buy rating and raised its price target to US$28.00 from US$24.00.
Phreesia (PHR) — Barclays set a US$11.00 price target.
PPL (PPL) — Barclays maintained its Overweight rating with a US$38.00 price target.
Principal Financial Group (PFG) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$113.00 from US$115.00.
Promis Neurosciences (PMN) — H.C. Wainwright maintained its Buy rating.
Protagonist Therapeutics (PTGX) — Leerink Partners maintained its Outperform rating and raised its price target to US$190.00 from US$150.00.
Protagonist Therapeutics (PTGX) — UBS initiated coverage with a Buy rating and a US$184.00 price target.
Prudential Financial (PRU) — Mizuho set a US$108.00 price target.
Prudential Financial (PRU) — Piper Sandler maintained its Neutral rating and lowered its price target to US$120.00 from US$128.00.
Prudential Financial (PRU) — Wells Fargo maintained its Underweight rating and lowered its price target to US$104.00 from US$110.00.
PulteGroup (PHM) — Goldman Sachs set a US$138.00 price target.
Q32 Bio (QTTB) — Leerink Partners initiated coverage with an Outperform rating and a US$40.00 price target.
Quoin Pharmaceuticals (QNRX) — BTIG Research initiated coverage with a Buy rating and a US$14.00 price target.
Ralliant (RAL) — Citigroup maintained its Buy rating.
Rayonier (RYN) — Truist Securities maintained its Hold rating and lowered its price target to US$22.00 from US$24.00.
Red Rock Resorts (RRR) — Citigroup maintained its Buy rating.
Regal Rexnord (RRX) — Citigroup maintained its Buy rating.
Reinsurance Group of America (RGA) — Wells Fargo maintained its Overweight rating and raised its price target to US$292.00 from US$291.00.
RenaissanceRe (RNR) — TD Cowen maintained its Hold rating and raised its price target to US$320.00 from US$315.00.
RenaissanceRe (RNR) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$319.00 from US$331.00.
Rexford Industrial Realty (REXR) — Truist Securities maintained its Buy rating and raised its price target to US$39.00 from US$38.00.
Rhythm Pharmaceuticals (RYTM) — H.C. Wainwright maintained its Buy rating and raised its price target to US$130.00 from US$105.00.
Rithm Capital (RITM) — BTIG Research maintained its Buy rating and lowered its price target to US$12.00 from US$13.00.
RLI (RLI) — Wells Fargo maintained its Underweight rating and lowered its price target to US$51.00 from US$57.00.
Robinhood Markets (HOOD) — Evercore ISI initiated coverage with an Outperform rating and a US$130.00 price target.
Roblox (RBLX) — Wells Fargo downgraded its rating to Cautious from Overweight.
Rocket Companies (RKT) — JPMorgan maintained its Neutral rating and lowered its price target to US$12.50 from US$14.00.
Rocket Companies (RKT) — Morgan Stanley maintained its Overweight rating and lowered its price target to US$16.00 from US$19.00.
Roivant Sciences (ROIV) — Wolfe Research downgraded its rating to Peer Perform from Outperform.
Royal Caribbean Cruises (RCL) — Wells Fargo maintained its Overweight rating and lowered its price target to US$358.00 from US$388.00.
Ryan Specialty (RYAN) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$41.00 from US$43.00.
SailPoint (SAIL) — H.C. Wainwright maintained its Buy rating.
SailPoint (SAIL) — Stephens maintained its Overweight rating.
Salesforce (CRM) — Barclays downgraded its rating to Positive from Overweight.
Salesforce (CRM) — BofA Securities upgraded its rating to Buy from Underperform and raised its price target to US$285.00 from US$160.00.
Salesforce (CRM) — Deutsche Bank initiated coverage with a Buy rating.
Salesforce (CRM) — Evercore ISI initiated coverage with an Outperform rating.
Salesforce (CRM) — KeyCorp initiated coverage with a Sector Weight rating.
Salesforce (CRM) — TD Cowen initiated coverage with a Buy rating.
Salesforce (CRM) — Wells Fargo downgraded its rating to Underweight from Buy.
Schrodinger (SDGR) — BMO Capital Markets maintained its Outperform rating and raised its price target to US$30.00 from US$24.00.
Sempra Energy (SRE) — Barclays maintained its Overweight rating with a US$90.00 price target.
Sempra Energy (SRE) — JPMorgan maintained its Overweight rating and lowered its price target to US$99.00 from US$102.00.
ServiceNow (NOW) — BTIG Research maintained its Buy rating with a US$170.00 price target.
ServiceNow (NOW) — RBC Capital Markets maintained its Outperform rating and raised its price target to US$176.00 from US$130.00.
ServiceNow (NOW) — Wells Fargo maintained its Overweight rating with a US$190.00 price target.
Shattuck Labs (STTK) — UBS initiated coverage with a Buy rating and a US$17.00 price target.
Shell (SHEL) — Mizuho set a US$103.00 price target.
Shopify (SHOP) — Cantor Fitzgerald maintained its Neutral rating and raised its price target to US$158.00 from US$145.00.
Shoulder Innovations (SI) — BTIG Research maintained its Buy rating and raised its price target to US$27.00 from US$26.00.
Silgan (SLGN) — Truist Securities maintained its Buy rating and lowered its price target to US$45.00 from US$52.00.
Simon Property Group (SPG) — Piper Sandler maintained its Overweight rating and lowered its price target to US$254.00 from US$285.00.
SiteOne Landscape Supply (SITE) — Goldman Sachs set a US$100.00 price target.
Skyward Specialty Insurance Group (SKWD) — Citigroup maintained its Market Outperform rating.
SL Green Realty (SLG) — Piper Sandler maintained its Overweight rating and lowered its price target to US$64.00 from US$79.00.
Slide Insurance (SLDE) — Citigroup maintained its Outperform rating.
Slide Insurance (SLDE) — Citizens JMP maintained its Market Outperform rating and raised its price target to US$28.00 from US$27.00.
SLM Corporation (Sallie Mae) (SLM) — JPMorgan maintained its Underweight rating and lowered its price target to US$22.00 from US$25.00.
SLM Corporation (Sallie Mae) (SLM) — Morgan Stanley upgraded its rating to Overweight from Equal Weight with a US$30.00 price target.
Smurfit Westrock (SW) — Truist Securities maintained its Buy rating and lowered its price target to US$54.00 from US$57.00.
Snowflake (SNOW) — Needham & Company maintained its Buy rating with a US$450.00 price target.
SoFi Technologies (SOFI) — Keefe, Bruyette & Woods maintained its Underperform rating.
Sonoco Products (SON) — Truist Securities maintained its Buy rating and lowered its price target to US$62.00 from US$68.00.
SOPHiA GENETICS (SOPH) — H.C. Wainwright maintained its Buy rating with a US$14.00 price target.
SpaceX (SPCX) — Pivotal Research maintained its Buy rating with a US$230.00 price target.
Spotify Technology (SPOT) — Cantor Fitzgerald maintained its Neutral rating and lowered its price target to US$490.00 from US$530.00.
Spyre Therapeutics (SYRE) — UBS initiated coverage with a Buy rating and a US$120.00 price target.
Standard Motor Products (SMP) — Roth Capital maintained its Buy rating with a US$54.00 price target.
Stewart Information Services (STC) — Citigroup maintained its Market Outperform rating.
Stewart Information Services (STC) — Citizens JMP maintained its Market Outperform rating and lowered its price target to US$75.00 from US$80.00.
Stifel Financial (SF) — TD Cowen maintained its Hold rating and lowered its price target to US$78.00 from US$84.00.
Strive (ASST) — Maxim Group set a US$37.00 price target.
Stryker (SYK) — BTIG Research maintained its Buy rating and lowered its price target to US$316.00 from US$358.00.
Sylvamo (SLVM) — Truist Securities maintained its Buy rating and lowered its price target to US$40.00 from US$49.00.
Synchrony Financial (SYF) — JPMorgan maintained its Neutral rating and lowered its price target to US$74.00 from US$78.00.
Synchrony Financial (SYF) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$83.00 from US$84.00.
Synopsys (SNPS) — Needham & Company maintained its Buy rating and raised its price target to US$620.00 from US$580.00.
T-Mobile US (TMUS) — Raymond James upgraded its rating to Outperform from Market Perform with a US$170.00 price target.
T. Rowe Price Group (TROW) — TD Cowen maintained its Hold rating and lowered its price target to US$109.00 from US$110.00.
Tactile Systems Technology (TCMD) — BTIG Research maintained its Buy rating and lowered its price target to US$35.00 from US$39.00.
Take-Two Interactive Software (TTWO) — Wells Fargo maintained its Overweight rating.
Targa Resources (TRGP) — Citigroup raised its price target to US$325.00 from US$303.00.
Tectonic Therapeutic (TECX) — UBS initiated coverage with a Neutral rating and a US$26.00 price target.
Tempus AI (TEM) — Canaccord Genuity maintained its Buy rating and raised its price target to US$95.00 from US$80.00.
TeraWulf (WULF) — TD Cowen initiated coverage with a Buy rating and a US$21.00 price target.
Terreno Realty (TRNO) — BMO Capital Markets upgraded its rating to Outperform from Market Perform with a US$75.00 price target.
Terreno Realty (TRNO) — Piper Sandler maintained its Overweight rating and lowered its price target to US$85.00 from US$91.00.
Tesla (TSLA) — Jefferies maintained its Hold rating and raised its price target to US$400.00 from US$350.00.
Teva Pharmaceutical Industries (TEVA) — JPMorgan maintained its Overweight rating and raised its price target to US$50.00 from US$40.00.
The Hartford Insurance Group (HIG) — Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to US$137.00 from US$144.00.
The Hartford Insurance Group (HIG) — Truist Securities initiated coverage with a Hold rating and a US$137.00 price target.
The Hartford Insurance Group (HIG) — Wells Fargo maintained its Overweight rating and lowered its price target to US$158.00 from US$164.00.
Thermo Fisher Scientific (TMO) — Morgan Stanley maintained its Overweight rating with a US$730.00 price target.
TPG (TPG) — TD Cowen maintained its Buy rating and lowered its price target to US$60.00 from US$64.00.
Tractor Supply (TSCO) — UBS maintained its Neutral rating.
Transdigm Group (TDG) — Goldman Sachs maintained its Buy rating and lowered its price target to US$1,745.00 from US$1,972.00.
Twist Bioscience (TWST) — Canaccord Genuity maintained its Buy rating and raised its price target to US$205.00 from US$120.00.
Tyler Technologies (TYL) — Wells Fargo upgraded its rating to Overweight from Equal Weight and raised its price target to US$400.00 from US$335.00.
Uber Technologies (UBER) — Cantor Fitzgerald maintained its Overweight rating with a US$90.00 price target.
UL Solutions (ULS) — UBS maintained its Buy rating with a US$97.00 price target.
Unilever (UL) — Jefferies maintained its Underperform rating.
United Dominion Realty Trust (UDR) — Piper Sandler maintained its Neutral rating and lowered its price target to US$36.00 from US$41.00.
Unity Software (U) — Wells Fargo maintained its Overweight rating and raised its price target to US$53.00 from US$48.00.
Unum Group (UNM) — Wells Fargo maintained its Overweight rating and raised its price target to US$102.00 from US$100.00.
UWM (UWMC) — BTIG Research downgraded its rating to Neutral from Buy.
UWM (UWMC) — Morgan Stanley set a US$1.50 price target.
V.F. (VFC) — Barclays maintained its Overweight rating.
Vail Resorts (MTN) — Stifel Nicolaus maintained its Buy rating and raised its price target to US$172.00 from US$157.00.
Vaxcyte (PCVX) — Cantor Fitzgerald maintained its Overweight rating with a US$120.00 price target.
Vera Therapeutics (VERA) — Leerink Partners initiated coverage with a Market Perform rating and a US$34.00 price target.
Versigent (VGNT) — RBC Capital Markets maintained its Outperform rating and raised its price target to US$53.00 from US$52.00.
Virtus Investment Partners (VRTS) — TD Cowen maintained its Hold rating and lowered its price target to US$136.00 from US$155.00.
Visa (V) — Robert W. Baird maintained its Outperform rating and raised its price target to US$430.00 from US$420.00.
Visteon (VC) — RBC Capital Markets maintained its Outperform rating and lowered its price target to US$127.00 from US$129.00.
Vivmark Residential Common Shares of Beneficial Interest (VMRK) — Piper Sandler maintained its Neutral rating and lowered its price target to US$67.00 from US$76.00.
Vornado Realty Trust (VNO) — Piper Sandler maintained its Neutral rating and lowered its price target to US$37.00 from US$44.00.
Voya Financial (VOYA) — Wells Fargo maintained its Equal Weight rating and lowered its price target to US$102.00 from US$104.00.
Vylor (VYLR) — UBS initiated coverage with a Buy rating and a US$89.00 price target.
W.R. Berkley (WRB) — Wells Fargo maintained its Underweight rating and lowered its price target to US$65.00 from US$68.00.
Watsco (WSO) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$330.00 from US$370.00.
Western Digital (WDC) — UBS set a US$470.00 price target.
Weyerhaeuser (WY) — Truist Securities maintained its Hold rating and lowered its price target to US$24.00 from US$28.00.
Whirlpool (WHR) — Citigroup maintained its Neutral rating.
Whirlpool (WHR) — Goldman Sachs maintained its Neutral rating and lowered its price target to US$41.00 from US$48.00.
Williams-Sonoma (WSM) — UBS maintained its Neutral rating.
Willis Towers Watson Public (WTW) — Wells Fargo maintained its Overweight rating and lowered its price target to US$364.00 from US$378.00.
WillScot (WSC) — Robert W. Baird maintained its Neutral rating and lowered its price target to US$21.00 from US$28.00.
Wyndham Hotels & Resorts (WH) — Morgan Stanley maintained its Overweight rating and raised its price target to US$92.00 from US$91.00.
Xylem (XYL) — Citigroup maintained its Buy rating.
Zebra Technologies (ZBRA) — Citigroup maintained its Buy rating.
Zeta Global (ZETA) — Craig Hallum set a US$38.00 price target.
Zeta Global (ZETA) — Roth Capital maintained its Buy rating and raised its price target to US$55.00 from US$44.00.
ZIM Integrated Shipping Services (ZIM) — JPMorgan maintained its Underweight rating and raised its price target to US$22.00 from US$16.50.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.